WeLeader Biomedical Co Dividend
The Dividend of WeLeader Biomedical Co (7713.TWO) as of Aug 20, 2026 is 3.37 TWD. In the previous year, Dividend was 2.30 TWD — a change of 46.43% (higher).
Get this data via API
Financial Data API
Dividend
3.37TWD
YoY
46.43%
Dividend yield
4.74 %
Last updated:
How much dividend does WeLeader Biomedical Co 2026 pay?
According to the latest status from August 2026, WeLeader Biomedical Co paid a total of 3.37 TWD per share in dividends within the last 12 months. With the current WeLeader Biomedical Co price of 71.10 TWD, this corresponds to a dividend yield of 4.76 %. A dividend is paid times per year.
At today's price the dividend yield works out to roughly 4.74%.
Historical WeLeader Biomedical Co Dividends
A dividend is paid times per year. Last year, the payout months were and July.
| Paydate | Dividend |
|---|---|
| 7/3/2025 | 3.37TWD |
| 7/13/2024 | 2.30TWD |
WeLeader Biomedical Co dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Is the WeLeader Biomedical Co Dividend Safe?
WeLeader Biomedical Co has been increasing the dividend for 1 years.
Analysts expect a Dividend Increase of 9.54% for the current fiscal year.
WeLeader Biomedical Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Dividend Details
Understanding WeLeader Biomedical Co's Dividend Distributions
WeLeader Biomedical Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining WeLeader Biomedical Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
WeLeader Biomedical Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in WeLeader Biomedical Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
WeLeader Biomedical Co Stock analysis
Frequently Asked Questions about WeLeader Biomedical Co stock
Over the past 12 months, WeLeader Biomedical Co paid a dividend of 3.37 TWD . This corresponds to a dividend yield of about 4.74 %. For the coming 12 months, WeLeader Biomedical Co is expected to pay a dividend of 3.37 TWD.
The current dividend yield of WeLeader Biomedical Co is 4.74 %.
WeLeader Biomedical Co paid dividends every year for the past 2 years.
For the upcoming 12 months, dividends amounting to 3.37 TWD are expected. This corresponds to a dividend yield of 4.76 %.
WeLeader Biomedical Co is assigned to the 'Health' sector.
To receive the latest dividend of WeLeader Biomedical Co from amounting to 3.37 TWD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, WeLeader Biomedical Co distributed 2.3 TWD as dividends.
The dividends of WeLeader Biomedical Co are distributed in TWD.
All Key Metrics — WeLeader Biomedical Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth